Trial
NCT02516436
The Safety of Using Buprenorphine With Naloxone in a Buccal Film to Initiate Treatment of Opioid Dependent Subjects
Phase IIIWITHDRAWNREGULATORYConfidence: MEDIUM
Sponsor
BioDelivery Sciences International
Collaborators
—
Condition
Opioid Dependence
Intervention
BEMA Buprenorphine NX
Why stopped
FDA did not require a clinical trial for indication.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-05-04